This suggests a connection between gut microbiota modulation and symptom alleviation, pointing to a potential mechanism by which SFN exerts neurobehavioral benefits
The FDA has formally approved Wegovy and Mounjaro for the following uses: Wegovy: Long-term weight management, along with diet and exercise, in: adults and children ages 12 years and older who have obesity adults who are overweight and have a weight-related health condition, such as high cholesterol, high blood pressure, or diabetes To decrease the risk of serious cardiovascular problems in adults who have cardiovascular disease and are overweight or have obesity Long-term treatment of metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis in adults Mounjaro: Long-term management of blood sugar levels, along with diet and exercise, in adults with type 2 diabetes Wegovy and Mounjaro are both prescribed for weight loss and long-term weight management
Gallbladder Disease: Increased risk of gallstones, especially in individuals with existing gallbladder problems
Your body needs iron to make hemoglobin, the protein in red blood cells that carries oxygen
Topiramate, known under the brand name Topamax, is an anti-seizure drug that was initially introduced as an epilepsy treatment in 1996